In the fast-evolving world of reproductive technology, Conceivable Life Sciences is making waves with their groundbreaking approach to automating the IVF lab process. Picture this: sleek, white robotic machines working seamlessly in IVF labs across the globe, revolutionizing the way fertility treatments are carried out. With just a push of a button, Conceivable’s cutting-edge robots are capable of intricate tasks such as immobilizing sperm with lasers, extracting them into needles, delicately placing them inside eggs sourced from fluid, and efficiently freezing resulting embryos in liquid nitrogen. It’s a marvel of modern science that has already helped eleven women achieve pregnancy, marking a significant milestone in the field of assisted reproductive technology.
Leading the charge at Conceivable is the renowned embryologist Jacques Cohen, the company’s chief scientific officer, who skillfully guided the robots through the complex process of intracytoplasmic sperm injection (ICSI) using his trusty keyboard and mouse. This feat, captured in awe-inspiring video footage, solidified Conceivable’s position as the first company to successfully implement robotic ICSI. With a substantial $20 million in venture capital funding, Conceivable is making a bold bet that robots are the future of IVF, and they’re leaving no stone unturned in their quest for innovation.
The secret behind Conceivable’s robotic prowess lies in their meticulous attention to detail when it comes to hardware. Drawing inspiration from the world of chip manufacturing and lab automation, Conceivable spared no expense in acquiring state-of-the-art motors that enable their fleet of around 20 robots to execute movements as precise as five millionths of a millimeter. By combining cutting-edge sensors and miniature tools, Conceivable has created a powerhouse of robotic technology that is set to redefine the IVF landscape.
But before their robots could work their magic on human eggs, Conceivable took a hands-on approach by conducting rigorous practice sessions using hamster and rabbit eggs at their headquarters in Guadalajara. The AI system developed by Conceivable seamlessly scanned the dish of fluid for eggs, utilizing advanced 3-D imaging technology to identify and select the most viable candidates. Dividing the eggs between human embryologists and their own robots, Conceivable initiated a groundbreaking experiment that showcased the potential of their robotic systems in comparison to traditional lab practices.
Looking ahead, Conceivable aims to collaborate with existing IVF centers to integrate their robotic solutions into conventional labs, offering a compelling alternative to traditional methods. As private-equity firms increasingly invest in IVF clinics, Conceivable sees an opportunity to drive growth and enhance outcomes through their cutting-edge technology. With the future of IVF looking brighter than ever, Conceivable is well-positioned to lead the charge towards a new era of assisted reproductive technology.